| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3821080 | La Presse Médicale | 2008 | 8 Pages |
Abstract
Patients with abdominal obesity and other classic risk factors are at high cardiovascular risk and require strict monitoring of their blood pressure, LDL-c, and blood glucose. New pharmacological strategies might help manage both abdominal obesity and its metabolic consequences.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Ãric Bruckert,